1. Home
  2. AREN vs SCLX Comparison

AREN vs SCLX Comparison

Compare AREN & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Arena Group Holdings Inc.

AREN

The Arena Group Holdings Inc.

HOLD

Current Price

$0.90

Market Cap

53.3M

Sector

Health Care

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.48

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AREN
SCLX
Founded
2016
2011
Country
United States
United States
Employees
N/A
34
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.3M
52.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AREN
SCLX
Price
$0.90
$9.48
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$8.00
N/A
AVG Volume (30 Days)
188.9K
119.0K
Earning Date
05-08-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
191.93
N/A
EPS
N/A
N/A
Revenue
$16,892,000.00
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
$5.00
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
27.46
N/A
52 Week Low
$0.81
$4.20
52 Week High
$7.85
$34.27

Technical Indicators

Market Signals
Indicator
AREN
SCLX
Relative Strength Index (RSI) 34.84 63.02
Support Level $0.81 $7.73
Resistance Level $1.61 $12.32
Average True Range (ATR) 0.11 0.94
MACD 0.02 0.24
Stochastic Oscillator 21.40 78.36

Price Performance

Historical Comparison
AREN
SCLX

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The company has four reportable segments: Sports & Leisure, Finance, Lifestyle, and Platform & Other. The company generates revenue from Sports & Leisure. Geographically, the company operates in United States; and Others. It generates maximum revenue from United States.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: